Heart failure & cardiomyopathiesResearch article
Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications
- State-of-the-art review
Study context
- Population
- Patients with HF facing out-of-pocket medication costs, US health care system as an illustrative example
Main finding
As reported in the abstract
Contributors to and solutions for high OOP costs of HF medications
Upcoming US policy change: cap on out-of-pocket (OOP) drug spending for Medicare Part D Plans in 2025
$2,000
Original publication
Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications. J Am Coll Cardiol. Published 8 January 2025. doi:10.1016/j.jacc.2024.11.011
Summarised from the published abstract; every number is checked against it